Pregabalin is NOT indicated for adjustment disorder and should not be used for this condition
Pregabalin lacks FDA approval and evidence-based support for treating adjustment disorder. The available evidence exclusively addresses neuropathic pain conditions (diabetic neuropathy, postherpetic neuralgia, spinal cord injury pain), fibromyalgia, partial seizures, and generalized anxiety disorder 1. Adjustment disorder is fundamentally different from these conditions and requires different therapeutic approaches.
Critical Clinical Context
For a 36-year-old patient prone to side effects, pregabalin is particularly problematic because:
- Pregabalin causes dose-dependent dizziness and sedation that can be reduced only by starting low and titrating slowly 2
- The drug produces somnolence, dizziness, weight gain, diplopia, and blurred vision as common adverse effects 1, 3
- Even at therapeutic doses for approved indications, discontinuation rates due to adverse effects are significant 4
Why This Matters for Your Patient
Adjustment disorder is a stress-related condition characterized by emotional or behavioral symptoms in response to identifiable stressors. It typically responds to:
- Psychotherapy (particularly cognitive-behavioral approaches)
- Brief supportive interventions
- Time-limited use of SSRIs or benzodiazepines if severe anxiety/depression is present
Pregabalin would expose your side-effect-sensitive patient to unnecessary risks without evidence of benefit for their actual diagnosis.
If Anxiety is the Target Symptom
If you're considering pregabalin because anxiety is prominent in this adjustment disorder presentation, note that:
- For generalized anxiety disorder (GAD), pregabalin dosing starts at 150 mg/day (75 mg twice daily), increasing to 300 mg/day within 1 week, with a licensed range of 150-600 mg/day 3, 4
- However, adjustment disorder with anxiety is NOT the same as GAD
- The evidence for pregabalin in anxiety is specific to GAD, not adjustment disorders 3, 4
Practical Dosing IF Pregabalin Were Appropriate (Which It Isn't)
For a side-effect-sensitive patient with normal renal function, if pregabalin were indicated:
Start extremely low: 25-50 mg at bedtime (lower than standard starting doses)
- Standard starting dose is 50 mg three times daily or 75 mg twice daily 2, 1
- For your patient, begin with 25-50 mg once daily at bedtime to assess tolerance
Titrate very slowly: Increase by 25-50 mg every 5-7 days
- Standard titration increases by 150 mg every 3-7 days 2
- Your patient needs slower escalation given side effect sensitivity
Target dose depends on indication:
- Neuropathic pain: 300 mg/day minimum effective dose, up to 600 mg/day maximum 2
- GAD: 300-450 mg/day effective range 3, 4
Monitor closely for:
- Dizziness and somnolence (most common, dose-dependent) 2, 3
- Weight gain
- Visual disturbances
- Cognitive effects (confusion, word-finding difficulty) 5
The Bottom Line
Do not prescribe pregabalin for adjustment disorder. Consider evidence-based treatments for this diagnosis: psychotherapy, supportive care, and if pharmacotherapy is needed, SSRIs or short-term benzodiazepines. If you're treating a comorbid condition for which pregabalin IS indicated (neuropathic pain, fibromyalgia, GAD), start at 25-50 mg at bedtime and titrate by 25-50 mg every 5-7 days, which is slower than standard protocols but appropriate for a side-effect-sensitive patient 2.